160 related articles for article (PubMed ID: 31444625)
1. Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.
Tsuyama S; Saito T; Akazawa Y; Yanai Y; Yatagai N; Akaike K; Hayashi T; Suehara Y; Takahashi F; Takamochi K; Hashimoto T; Kajiyama Y; Tsurumaru M; Fukunaga T; Yao T
Virchows Arch; 2019 Oct; 475(4):415-424. PubMed ID: 31444625
[TBL] [Abstract][Full Text] [Related]
2. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
Amatya VJ; Takeshima Y; Kaneko M; Inai K
Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction.
Suzuki H; Moriya J; Nakahata A; Fujioka Y; Inoue K; Nagashima K
Hum Pathol; 1998 Jul; 29(7):662-7. PubMed ID: 9670821
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
6. Esophageal carcinosarcoma: a genetic analysis.
Iwaya T; Maesawa C; Tamura G; Sato N; Ikeda K; Sasaki A; Othuka K; Ishida K; Saito K; Satodate R
Gastroenterology; 1997 Sep; 113(3):973-7. PubMed ID: 9287991
[TBL] [Abstract][Full Text] [Related]
7. True carcinosarcoma of the esophagus.
Iwaya T; Maesawa C; Uesugi N; Kimura T; Ogasawara S; Ikeda K; Kimura Y; Mitomo S; Ishida K; Sato N; Saito K; Masuda T
Dis Esophagus; 2006; 19(1):48-52. PubMed ID: 16364045
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
[TBL] [Abstract][Full Text] [Related]
9. Carcinosarcoma of esophagus. Report of one case and review of the literature.
Hu TH; Chien CS; Hsieh MJ; Lin CC
Changgeng Yi Xue Za Zhi; 1992 Sep; 15(3):161-6. PubMed ID: 1468040
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing.
Zhang X; Bai Q; Xu Y; Wang W; Chen L; Han J; Zhu H; Zhang Z; Hou Y; Zhou J; Zhou Y; Ji Y
Histopathology; 2019 May; 74(6):944-958. PubMed ID: 30629754
[TBL] [Abstract][Full Text] [Related]
11. A case of esophageal sarcomatoid carcinoma with molecular evidence of a monoclonal origin.
Kashiwabara K; Sano T; Oyama T; Najahima T; Makita F; Hashimoto N; Iwanami K; Kawashima O; Matsumoto T; Matsuzaki Y
Pathol Res Pract; 2001; 197(1):41-6. PubMed ID: 11209815
[TBL] [Abstract][Full Text] [Related]
12. Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into Tumorigenesis.
Saijo M; Nakamura K; Ida N; Nasu A; Yoshino T; Masuyama H; Yanai H
Am J Surg Pathol; 2019 Nov; 43(11):1493-1500. PubMed ID: 31478942
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour.
Bai Q; Zhang X; Zhu X; Wang L; Huang D; Cai X; Zhou X; Wang J; Sheng W
Histopathology; 2016 Sep; 69(3):393-405. PubMed ID: 27307095
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological studies of esophageal carcinosarcoma: analyses of its morphological characteristics using endoscopic, histological, and immunohistochemical procedures.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kenmochi T; Himeno H; Tsuchida T; Kawai K; Tanaka M; Machimura T; Tajima T; Makuuchi H
Endoscopy; 2000 Sep; 32(9):706-11. PubMed ID: 10989995
[TBL] [Abstract][Full Text] [Related]
15. So-called carcinosarcoma of the esophagus: A clinicopathologic, immunohistochemical and DNA flow-cytometric analysis of 6 cases.
Natsugoe S; Matsushita Y; Chuman Y; Kijima F; Haraguchi Y; Shimada M; Yoshinaka H; Baba M; Mueller J; Aikou T
Oncology; 1999 Jul; 57(1):29-35. PubMed ID: 10394122
[TBL] [Abstract][Full Text] [Related]
16. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Suzuki S; Yokobori T; Sakai M; Tanaka N; Inose T; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Ojima H; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Kuwano H
Oncol Rep; 2013 Jun; 29(6):2119-26. PubMed ID: 23546020
[TBL] [Abstract][Full Text] [Related]
18. Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma.
Lin CS; Wang LS; Chang SC; Chou TY; Hsu WH; Liu CS; Lee MH; Chung MY; Wei YH
Oncol Rep; 2012 Jul; 28(1):69-76. PubMed ID: 22505350
[TBL] [Abstract][Full Text] [Related]
19. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
[TBL] [Abstract][Full Text] [Related]
20. p53 immunoreactivity in carcinosarcoma of the esophagus.
Casson AG; Kerkvliet N; O'Malley F; Inculet R; Troster M
J Surg Oncol; 1994 Jun; 56(2):132-5. PubMed ID: 8007679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
